Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Endocrine Therapy with Letrozole and Leuprolide in Premenopausal Breast Cancer
NCT00903162Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- May 2009
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Dana-Farber Cancer Institute. Started May 2009; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00903162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903162.